Management algorithms for metastatic prostate cancer
نویسندگان
چکیده
منابع مشابه
Prostate Cancer Management of Metastatic Castration-resistant Prostate Cancer
The management of men with metastatic castration-resistant prostate cancer (CRPC) has taken several leaps forwards in the last two years, with the demonstration of improved overall survival with three novel agents (sipuleucel-T, cabazitaxel and abiraterone acetate) and a significant delay in skeletal-related events observed with denosumab. The pipeline of systemic therapies in prostate cancer r...
متن کاملThe management of metastatic prostate cancer
Bone is the most common site for metastatic deposits in men with prostate cancer. Metastatic bone disease is a catastrophic complication which can cause problems such as skeletal related events, hypercalcaemia, anaemia, spinal cord compression and signifies that the malignant process is incurable. It is important that nurses managing a caseload of patients which includes individuals with, or at...
متن کاملhormone therapy in metastatic prostate cancer
only orchiectomy is still commonly used today either as a single therapy or in combination regimens. hypophysectomy & adrenalectomy showed such devastating effects on the endocrine equilibrium as to be inconsistent with an acceptable quality of life or even with survival. chemical adrenalectomy was also tried with drugs (eg. aminoglutethmide, spironolactone) leading to consequences superimposab...
متن کاملManagement of Advanced/Metastatic Prostate Cancer: 2000 Update
Hormonal therapy, as currently administered, produces a dramatic response followed by a disappointing progression. Can we alter the grim prognosis of advanced prostate cancer by using novel agents, by delivering hormonal therapy earlier in the course of the disease, or by using innovative means such as intermittent therapy? Most likely we will, but not imminently. Meanwhile we need to ask, what...
متن کاملManagement of Hormone-Sensitive and Hormone-Refractory Metastatic Prostate Cancer.
BACKGROUND: Prostate cancer is a significant health problem in the United States and is the focus of increasing attention in our society. With the aging of the US population, it is likely that prostate cancer will continue to grow in importance. The options for systemic therapy of metastatic prostate cancer should be familiar to physicians, including nonspecialists, whose patients seek their ad...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Canadian Urological Association Journal
سال: 2019
ISSN: 1920-1214,1911-6470
DOI: 10.5489/cuaj.5840